![Frontiers | Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study Frontiers | Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study](https://www.frontiersin.org/files/Articles/824831/fpsyt-13-824831-HTML/image_m/fpsyt-13-824831-g001.jpg)
Frontiers | Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
![Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior | Translational Psychiatry Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior | Translational Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41398-019-0466-x/MediaObjects/41398_2019_466_Fig1_HTML.png)
Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior | Translational Psychiatry
![Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression | Translational Psychiatry Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression | Translational Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41398-020-01097-6/MediaObjects/41398_2020_1097_Fig1_HTML.png)
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression | Translational Psychiatry
![Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41398-019-0507-5/MediaObjects/41398_2019_507_Fig3_HTML.png)
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry
![Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41398-019-0507-5/MediaObjects/41398_2019_507_Fig2_HTML.png)
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry
![PDF) Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression PDF) Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression](https://www.researchgate.net/publication/349739671/figure/fig1/AS:1003874932502528@1616353843291/Change-in-metabolite-levels-from-pre-treatment-to-8-weeks-post-treatment-with_Q320.jpg)